NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

FDA recall notice · announced March 23, 2016 · Teva Pharmaceuticals

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Reason for recall

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Notes

Distribution: Nationwide and Puerto Rico.
Lot/code information: Lot #: 05N533, Exp 11/16
Quantity: 576 bottles
Status: Terminated
Products in this recall event:
- NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL (D-0773-2016)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.